Showing results (1521-1530 of 2,482) with videos related to

Sort By:
Pageof 249
Clinical and Translational Science|December 5, 2015
Building Interdisciplinary Research Models Through Interactive EducationAmanda J Hessels, Brian Robinson, Michael O'Rourke, et al.
Clinical and Translational Science|December 6, 2017
Pharmacogenetic Analysis of the Model-Based Pharmacokinetics of Five Anti-HIV Drugs: How Does This Influence the Effect of Aging?Jingxian Chen, Farida S Akhtari, Michael J Wagner, et al.
Clinical and Translational Science|December 2, 2017
Inflammatory and Physiological Consequences of Debridement of Fibrous Tissue after Volumetric Muscle Loss InjuryBenjamin T Corona, Jessica C Rivera, Sarah M Greising
Clinical and Translational Science|December 13, 2017
S-Nitrosohemoglobin Levels and Patient Outcome After Transfusion During Pediatric Bypass SurgeryFaisal Matto, Peter C Kouretas, Richard Smith, et al.
Clinical and Translational Science|September 1, 2017
LY3127760, a Selective Prostaglandin E4 (EP4) Receptor Antagonist, and Celecoxib: A Comparison of Pharmacological ProfilesYan Jin, Claire Smith, Leijun Hu, et al.
Clinical and Translational Science|September 12, 2017
A Pilot Dose-Finding Study of Etanercept in Rheumatoid ArthritisFerdinand C Breedveld, Heather E Jones, Kim Peifer, et al.
Clinical and Translational Science|March 3, 2018
Opportunities and Challenges in Implementation of Multiparameter Single Cell Analysis Platforms for Clinical TranslationSusan M Keating, D Lansing Taylor, Anne L Plant, et al.
Clinical and Translational Science|November 7, 2017
Population Pharmacokinetics of Fosdagrocorat (PF-04171327), a Dissociated Glucocorticoid Receptor Agonist, in Patients With Rheumatoid ArthritisBarry Weatherley, Lynn McFadyen, Brinda Tammara
Clinical and Translational Science|January 20, 2018
Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons LearnedKristin W Weitzel, D Max Smith, Amanda R Elsey, et al.
Clinical and Translational Science|January 1, 2019
PF-04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo-Controlled StudyRobert J Charnigo, David Beidler, Denis Rybin, et al.
Pageof 249